The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Age Factors
Concept Immunologic Factors
Concept Fibroblast Growth Factors
Concept Insulin-Like Growth Factor I
Concept Risk Factors
Concept Time Factors
Concept Receptors, Tumor Necrosis Factor
Concept Tumor Necrosis Factors
Concept Sex Factors
Concept Fibroblast Growth Factor 10
Concept Biological Factors
Concept Granulocyte-Macrophage Colony-Stimulating Factor
Academic Article Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
Academic Article Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Academic Article A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
Academic Article A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Academic Article Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Academic Article An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Academic Article Infliximab in Crohn's disease: first anniversary clinical experience.
Academic Article Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Academic Article Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?
Academic Article Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Academic Article Smoking and inflammatory bowel disease.
Academic Article Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Academic Article Biologics in peri-operative management of Crohn's disease.
Academic Article Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.
Academic Article Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Academic Article Immunogenicity of infliximab in Crohn's disease.
Academic Article Factoring in growth factors II.
Academic Article Crohn's disease: step up or top down therapy.
Academic Article Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Academic Article Factoring in growth factors for treatment of inflammatory bowel disease.
Academic Article Review article: the long-term management of ulcerative colitis.
Academic Article Unemployment and disability in patients with moderately to severely active Crohn's disease.
Academic Article An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
Academic Article Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
Academic Article Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
Academic Article American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Academic Article Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Academic Article Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Academic Article Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
Academic Article Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
Academic Article Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
Academic Article Sarcopenia and the elusive fountain of youth.
Academic Article Selecting appropriate anti-TNF agents in inflammatory bowel disease.
Academic Article Optimizing conventional therapies for inflammatory bowel disease.
Academic Article Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.
Academic Article Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
Academic Article Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Academic Article General principles and pharmacology of biologics in inflammatory bowel disease.
Academic Article Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
Academic Article Addicted to acid suppression.
Academic Article Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Academic Article Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.
Academic Article African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
Academic Article Inflammatory bowel disease.
Academic Article Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Academic Article The role of biologics in ulcerative colitis.
Academic Article Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Academic Article Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Academic Article Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.
Academic Article Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Academic Article Treatment of inflammatory bowel disease: a review of medical therapy.
Academic Article Disease modification in inflammatory bowel disease.
Academic Article Update on the management of ulcerative colitis.
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article Treatment of Crohn's disease: the "long" of it.
Academic Article Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Academic Article Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
Academic Article Infliximab for induction and maintenance therapy for ulcerative colitis.
Academic Article The 'tipping point' applied.
Academic Article Practical application of anti-TNF therapy for luminal Crohn's disease.
Academic Article The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Academic Article Optimal timing of colonoscopy to screen for cancer in ulcerative colitis.
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article "Hit me with your best shot... Fire away!".
Academic Article Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Academic Article Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
Academic Article Lack of association between oral contraceptive use and ulcerative colitis.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.
Academic Article Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
Academic Article Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.
Academic Article Commentary: pre-operative use of anti-TNF-a agents and the risk of post-operative complications in patients with ulcerative colitis.
Academic Article Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Academic Article Medical therapy to reduce postoperative Crohn's disease recurrence.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Academic Article Modifying risk factors: do the means justify the ends?
Academic Article Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Academic Article Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Academic Article Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article Heading back to the trough (levels of biologics in IBD).
Academic Article Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
Academic Article Still in pursuit.
Academic Article American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Academic Article Comparing guidelines for the treatment of inflammatory bowel disease.
Academic Article Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Academic Article Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Academic Article Treat to target: a proposed new paradigm for the management of Crohn's disease.
Academic Article Reply: To PMID 25311382.
Academic Article Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
Academic Article Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
Academic Article Optimizing pharmacologic management of inflammatory bowel disease.
Academic Article Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Academic Article Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Academic Article Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Academic Article Targeting Crohn's disease.
Academic Article Inflammatory Bowel Disease and the Risk of Prostate Cancer.
Academic Article Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases.
Academic Article Checkpoint Inhibitor-Induced Colitis.
Academic Article Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
Academic Article Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
Academic Article The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications.
Academic Article Patient Perspectives on Medical Trauma Related to Inflammatory Bowel Disease.
Academic Article Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
Academic Article Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).
Academic Article Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
Concept Tumor Necrosis Factor alpha-Induced Protein 3
Academic Article Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Academic Article Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Search Criteria
  • F Factor